Shareholders of the medtech company Getinge are invited to the Annual General Meeting on Tuesday, April 21, in Halmstad. Shareholders may also cast their votes in advance by mail.
The Board of Directors proposes that the meeting approves a dividend of 4.75 Swedish kronor per share.
The Nomination Committee proposes the election of Camilla Sylvest as a new board member. She previously served as Executive Vice President of Commercial Strategy and Corporate Affairs at Novo Nordisk and has also held the position of General Manager for operations in Denmark, Germany, Southeast Asia, and China.
Board member Malin Persson has declined re-election.
The re-election of Chairman Johan Malmquist and board members Carl Bennet, Johan Bygge, Cecilia Daun Wennborg, Dan Frohm, Mattias Perjos, Kristian Samuelsson, and Ulrika Dellby is proposed.
The Board seeks authorization from the meeting to decide on the acquisition of the company's own shares.
Getinge AB is a Sweden-based company operating within healthcare sector. The Company provides hospitals and Life Science institutions with products and solutions aimed at improving clinical outcomes and optimizing workflows. The Company’s reporting segments have the following activities: Acute Care Therapies develops solutions for life-sustaining care in acute health conditions. Life Science offers a comprehensive range of equipment, technical expertise and prevention consultation contamination in pharmaceutical production, biomedical research, production of medical equipment and in various laboratory applications. Surgical Workflows offers products and services for the effective disinfection and sterilization of instruments used in operations, operating tables and others hardware for operating rooms and advanced IT systems for efficient and secure workflows in hospitals.
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
